NCT07020546 Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
| NCT ID | NCT07020546 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Generation Next Fertility |
| Condition | Infertility |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2025-07-08 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2025-07-08 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.
Eligibility Criteria
Inclusion Criteria: * No none contraindications to IVF or PRP treatment * Adequate ovarian reserves and AMH level * Willingness to undergo two IVF cycles and oPRP treatment Exclusion Criteria: * Anovulation due to menopause or perimenopause * Any health conditions that are contraindicated for IVF or oPRP treatment
Contact & Investigator
Jesse Hade, MD
PRINCIPAL INVESTIGATOR
Generation Next Fertility
Frequently Asked Questions
Who can join the NCT07020546 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 47 Years, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07020546 currently recruiting?
Yes, NCT07020546 is actively recruiting participants. Contact the research team at a.broussard@generationnextfertility.com for enrollment information.
Where is the NCT07020546 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07020546 clinical trial?
NCT07020546 is sponsored by Generation Next Fertility. The principal investigator is Jesse Hade, MD at Generation Next Fertility. The trial plans to enroll 180 participants.